Journal profile · Pathology
Medical Molecular Morphology
ISSN 1860-1480 · eISSN 1860-1499 · Springer Singapore · JAPAN · Quarterly · Founded 1993
Medical Molecular Morphology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4; hybrid open access; APC about USD 4,390; median 78 days to acceptance (69 articles, last 24 months); community-reported acceptance: easy; 35 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Medical Molecular Morphology is published by Springer Singapore and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Oral and Maxillofacial Pathology, Sarcoma Diagnosis and Treatment and Neuroendocrine Tumor Research Advances, together about 18.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Medical Molecular Morphology is an international forum for researchers in both basic and clinical medicine to present and discuss new research on the structural mechanisms and the processes of health and disease at the molecular level. The structures of molecules, organelles, cells, tissues, and organs determine their normal function. Disease is thus best understood in terms of structural changes in these different levels of biological organization, especially in molecules and molecular interactions as well as the cellular localization of chemical components. Medical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dental sciences using techniques for structural research such as electron microscopy, confocal laser scanning microscopy, enzyme histochemistry, immunohistochemistry, radioautography, X-ray microanalysis, and in situ hybridization. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.Reports of animal experiments must state that the "Principles of laboratory animal care"(NIH publication No. 86-23, revised 1985) were followed. The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Kenichi HaradaPublisher website
Editorial board by country: none in mainland China; most named Japan 17, United States 3, United Kingdom 1, France 1, Sweden 1 (25 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Oral and Maxillofacial PathologyDentistry6.7%
- Sarcoma Diagnosis and TreatmentMedicine5.8%
- Neuroendocrine Tumor Research AdvancesMedicine5.8%
- Cancer and Skin LesionsMedicine5.7%
- Liver Disease Diagnosis and TreatmentMedicine5.1%
- Cell Adhesion Molecules ResearchMedicine5.1%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine5.1%
- Barrier Structure and Function StudiesNeuroscience4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.4LetPub ·
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.5Publisher website ·
- CiteScore 2026-06
- 2.6LetPub ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.56LetPub ·
- h-index
- 39LetPub ·
- h-index
- 54OpenAlex ·
- i10-index
- 484OpenAlex ·
- 2-year mean citedness
- 1.57OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 24.27%LetPub ·
Volume
- Articles per year
- 33LetPub ·
- Downloads per year (publisher) 2025
- 109,100Publisher website ·
Articles by year OpenAlex count · 1,212 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 7 | 1 |
| 2025 | 35 | 12 | 50 |
| 2024 | 41 | 13 | 106 |
| 2023 | 34 | 9 | 117 |
| 2022 | 33 | 8 | 184 |
| 2021 | 38 | 10 | 257 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
78 daysMedian, submission to acceptance · P25–P75 50 days – 101 days
- Acceptance to online
- median 16 days (69 articles)
- Submission to online
- median 98 days
- Sample
- 69 articles with submission and acceptance dates (71 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,690 / GBP 2,890 | — | — | |
| Publisher website | JPY 10,000 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- JPY 10,000
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- ≥ 5
- Reference style
- Numbered, in order of citation
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted8
- case reportMedical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dent…Length not stated
- case reportsArticles may be in the form of original papers, reviews, case reports, or letters. The maximum length for each type of article is 10, 15, 5, and 1 printed pages…Length not stated
- letterMedical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dent…Length not stated
- lettersArticles may be in the form of original papers, reviews, case reports, or letters. The maximum length for each type of article is 10, 15, 5, and 1 printed pages…Length not stated
- original paperMedical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dent…Length not stated
- original papersArticles may be in the form of original papers, reviews, case reports, or letters. The maximum length for each type of article is 10, 15, 5, and 1 printed pages…Length not stated
- reviewMedical Molecular Morphology welcomes articles on basic or clinical research in the fields of cell biology, molecular biology, and medical, veterinary, and dent…Length not stated
- reviewsArticles may be in the form of original papers, reviews, case reports, or letters. The maximum length for each type of article is 10, 15, 5, and 1 printed pages…Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review
- Conflicts of interest Disclosure of confl icts of interest (COI)
COI disclosure required at submission with specific financial thresholds. Model summary
When a manuscript is submitted, authors must disclose any financial relationships they have with business enterprises or for-profit corporate organizations (hereafter referred to as 'Commercial Entities') regarding the subjects or materials treated in the research, if the amount exceeds the criteria specified below. 1) Position on the advisory board or board of directors at one or more Commercial …
Source ↗Publisher website ·- Data availability Data availability statements
Springer Nature research data policy; Data Availability Statement mandatory for original research. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics
Clinical studies require ethics committee approval statement with approval number. Model summary
If materials used in the study are from patients at clinics, it should be stated in the text that the study has been reviewed and approved by the ethics committee for clinical research in the research institutes where the study has been performed, accompanied by the number for the approval.
Source ↗Publisher website ·- License & copyright Copyright transfer
Authors will be asked to transfer copyright of the article to the Japanese Society for Clinical Molecular Morphology (or grant the Japanese Society for Clinical Molecular Morphology exclusive publication and dissemination rights). This will ensure the widest possible protection and dissemination of information under copyright laws. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Copyright transfer to the Japanese Society for Clinical Molecular Morphology. Model summary
To find out more about publishing your work Open Access in Medical Molecular Morphology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Peer-review system
Peer review: editorial board decides accept/reject in consultation with at least two referees. Model summary
The editorial board decides whether to accept or reject submitted papers in consultation with at least two referees. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Singapore
- Country or region
- JAPAN
- Language
- English
- Frequency
- Quarterly
- Founded
- 1993
- ISSN
- 1860-1480
- Electronic ISSN
- 1860-1499
- Latest issue on the website
- Volume 59, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Medical Molecular Morphology
What CAS zone is Medical Molecular Morphology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Medical Molecular Morphology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Medical Molecular Morphology?
The latest impact factor listed by LetPub is 1.4; CiteScore 2.6, h-index 54.
How long does peer review take at Medical Molecular Morphology?
Based on the dates recorded on 69 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 50–101 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Medical Molecular Morphology?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: ≥ 5; Reference style: Numbered, in order of citation; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Medical Molecular Morphology based?
Of the 25 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (17), United States (3) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Medical Molecular Morphology?
According to LetPub and DOAJ records, Medical Molecular Morphology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Medical Molecular Morphology open access, and what is the APC?
Medical Molecular Morphology is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .